LinkedIn Profile

Access Miracor Medical Systems GmbH historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Sector Industry
private:miracormedicalsystemsgmbh 874703 May 30th, 2019 12:00AM Miracor Medical SA 613 29.00 Open Medical Devices May 29th, 2019 08:36PM May 29th, 2019 08:36PM Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding. Open medical device, cardiology, cardiac surgery, marketing, sales, product development Open Rue de Bruxelles 174 Hognoul Walloon Region BE 4342 Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 17th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 16th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 15th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 14th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 13th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 12th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 11th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 10th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care
private:miracormedicalsystemsgmbh 874703 Feb 9th, 2018 12:00AM Miracor Medical Systems GmbH 390 26.00 Open Medical Devices Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding. Health Care Equipment & Services Health Care

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.